Long-term outcomes after systemic treatment of acute GVHD.P values express difference between patients treated with corticosteroids plus natalizumab and control patients treated with corticosteroids only. (A) NRM and (B) OS for all patients; (C) NRM and (D) OS for patients with AA2 scores; and (E) NRM and (F) OS for patients with AA3 scores.